Role of Nodal-PITX2C signaling pathway in glucose-induced cardiomyocyte hypertrophy

Biochemistry and Cell Biology

Volumn 92, Issue 3, 2014, Pages 183-190

  Su, Dongmei ^a   Jing, Sun ^a   Guan, Lina ^a   Li, Qian ^a   Zhang, Huiling ^a   Gao, Xiaobo ^a   Ma, Xu ^a  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

Cardiomyocyte hypertrophy; High glucose; Nodal; PITX2C; Smad4

Indexed keywords

GENES; GLUCOSE;

CARDIOMYOCYTES; HIGH GLUCOSE; NODAL; PITX2C; SMAD4;

PATHOLOGY;

ATRIAL NATRIURETIC FACTOR; GLUCOSE; PROTEIN NODAL; SMAD4 PROTEIN; SMALL INTERFERING RNA; HOMEODOMAIN PROTEIN; NODAL PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX2;

ARTICLE; CARDIOMYOCYTE HYPERTROPHY; CELL SURFACE; CONTROLLED STUDY; DRUG INDUCED DISEASE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HEART HYPERTROPHY; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; SIGNAL TRANSDUCTION; UPREGULATION; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; HEART MUSCLE CELL; HYPERTROPHY; METABOLISM; PATHOLOGY;

CELLS, CULTURED; GLUCOSE; HOMEODOMAIN PROTEINS; HUMANS; HYPERTROPHY; MYOCYTES, CARDIAC; NODAL PROTEIN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84901999721     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2013-0124     Document Type: Article

References (35)

1. Ang C.W. Nedjadi T. Sheikh A.A. Tweedle E.M. Tonack S. Honap S. et al 2010. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells. Carcinogenesis, 31 (9): 1541-1551. 10.1093/carcin/bgq137. 20622003.
2. Baburajendran N. Jauch R. Tan C.Y. Narasimhan K. Kolatkar P.R. 2011. Structural basis for the cooperative DNA recognition by Smad4 MH1 dimers. Nucleic Acids Res. 39 (18): 8213-8222. 10.1093/nar/gkr500. 21724602.
3. Bamforth S.D. Bragança J. Farthing C.R. Schneider J.E. Broadbent C. Michell A.C. et al 2004. Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat. Genet. 36 (11): 1189-1196. 10.1038/ng1446. 15475956. (Pubitemid 41288968)
4. Chen S. Khan Z.A. Karmazyn M. Chakrabarti S. 2007. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy. Diabetes Metab. Res. Rev. 23 (5): 356-367. 10.1002/dmrr.689. 17024690. (Pubitemid 47091238)
5. Ding F. Yu L. Wang M. Xu S. Xia Q. Fu G. 2013. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2. Amino Acids, 45 (2): 339-349. 10.1007/s00726-013-1504-2. 23665912.
6. Dong D.L. Chen C. Huo R. Wang N. Li Z. Tu Y.J. et al 2010. Reciprocal repression between mi-croRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension, 55 (4): 946-952. 10.1161/HYPERTENSIONAHA.109.139519. 20177001.
7. Duan Y. Zhou B. Su H. Liu Y. Du C. 2013. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300. Exp. Cell Res. 319 (3): 173-184. 10.1016/j.yexcr.2012.11.015. 23211718.
8. Dyntar D. Sergeev P. Klisic J. Ambühl P. Schaub M.C. Donath M.Y. 2006. High glucose alters cardiomyocyte contacts and inhibits myofibrillar formation. J. Clin. Endocrinol. Metab. 91 (5): 1961-1967. 10.1210/jc.2005-1904. 16522700.
9. Frey N. Olson E.N. 2003. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65: 45-79. 10.1146/annurev.physiol.65.092101.142243. 12524460. (Pubitemid 38249147)
10. Frey N. Katus H.A. Olson E.N. Hill J.A. 2004. Hypertrophy of the heart: a new therapeutic target? Circulation, 109: 1580-1589. 10.1161/01.CIR.0000120390. 68287.BB. 15066961. (Pubitemid 38451712)
11. Furtado M.B. Biben C. Shiratori H. Hamada H. Harvey R.P. 2011. Characterization of Pitx2c expression in the mouse heart using a reporter transgene. Dev. Dyn. 240 (1): 195-203. 10.1002/dvdy.22492. 21089073.
12. Ganga M. Espinoza H.M. Cox C.J. Morton L. Hjalt T.A. Lee Y. Amendt B.A. 2003. PITX2 isoform-specific regulation of atrial natriuretic factor expression: synergism and repression with Nkx2.5. J. Biol. Chem. 278: 22437-22445. 10.1074/jbc.M210163200. 12692125. (Pubitemid 36830296)
13. Hunter J.J. Chien K.R. 1999. Signaling pathways for cardiac hyper-trophy and failure. N. Engl. J. Med. 341 (17): 1276-1283. 10.1056/NEJM199910213411706. 10528039. (Pubitemid 29489744)
14. Kim T.G. Chen J. Sadoshima J. Lee Y. 2004. Jumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factors. Mol. Cell. Biol. 24 (23): 10151-10160. 10.1128/MCB.24.23.10151-10160.2004. 15542826. (Pubitemid 39507855)
15. Jeong K. Kwon H. Min C. Pak Y. 2009. Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts. Exp Mol Med. 41 (4): 226-235.
16. Levy D. Garrison R.J. Savage D.D. Kannel W.B. Castelli W.P. 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322 (22): 1561-1566. 10.1056/NEJM199005313222203. 2139921. (Pubitemid 20176696)
17. Li Y. Ma J. Zhu H. Singh M. Hill D. Greer P.A. et al 2011. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes. Diabetes, 60 (11): 2985-2994. 10.2337/db10-1333. 21911754.
18. Malhotra A. Kang B.P. Cheung S. Opawumi D. Meggs L.G. 2001. Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Diabetes, 50 (8): 1918-1926. 10.2337/diabetes.50. 8.1918. 11473056. (Pubitemid 33641614)
19. Massagué J. Seoane J. Wotton D. 2005. Smad transcription factors. Genes Dev. 19 (23): 2783-2810. 10.1101/gad.1350705. 16322555. (Pubitemid 41739965)
20. Menezes H.S. Barra M. Belló A.R. Martins C.B. Zielinsky P. 2001. Fetal myocardial hypertrophy in an experimental model of gestational diabetes. Cardiol. Young, 11 (6): 609-613. 10.1017/S1047951101000956. 11813911. (Pubitemid 33768605)
21. Modesti A. Bertolozzi I. Gamberi T. Marchetta M. Lumachi C. Coppo M. et al 2005. Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress. Diabetes, 54 (2): 394-401. 10.2337/diabetes.54.2.394. 15677497.
22. Molkentin J.D. Lu J.R. Antos C.L. Markham B. Richardson J. Robbins J. et al 1998. A calcineurin-dependent tran-scriptional pathway for cardiac hypertrophy. Cell, 93 (2): 215-228. 10.1016/S0092-8674(00)81573-1. 9568714. (Pubitemid 28180855)
23. Nadeem L. Munir S. Fu G. Dunk C. Baczyk D. Caniggia I. et al 2011. Nodal signals through activin receptor-like kinase 7 to inhibit trophoblast migration and invasion: implication in the pathogenesis of preeclampsia. Am. J. Pathol. 178 (3): 1177-1189. 10.1016/j.ajpath.2010.11.066. 21356369.
24. Nelson M.T. Herrera G.M. 2002. Molecular physiology: protecting the heart. Nature, 416: 273-274. 10.1038/416273a. 11907561.
25. Osadchii O.E. 2007. Cardiac hypertrophy induced by sustained be-ta-adrenoreceptor activation: pathophysiological aspects. Heart Fail. Rev. 12 (1): 66-86. 10.1007/s10741-007-9007-4. 17387610. (Pubitemid 46629248)
26. Parisi S. DAndrea D. Lago C.T. Adamson E.D. Persico M.G. Minchiotti G. 2003. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J. Cell Biol. 163 (2): 303-314. 10.1083/jcb.200303010. 14581455. (Pubitemid 37363131)
27. Passarella G. Trifirò G. Gasparetto M. Moreolo G.S. Milanesi O. 2013. Disorders in glucidic metabolism and congenital heart diseases: detection and prevention. Pediatr. Cardiol. 34 (4): 931-937. 10.1007/s00246-012-0577-0. 23229289.
28. Shen E. Diao X. Wang X. Chen R. Hu B. 2011. MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy. Am. J. Pathol. 179 (2): 639-650. 10.1016/j.ajpath. 2011.04.034. 21704010.
29. Strungaru M.H. Footz T. Liu Y. Berry F.B. Belleau P. Semina E.V. et al 2011. PITX2 is involved in stress response in cultured human trabecular meshwork cells through regulation of SLC13A3. Invest. Ophthalmol. Vis. Sci. 52 (10): 7625-7633. 10.1167/iovs.10-6967. 21873665.
30. ten Dijke P. Miyazono K. Heldin C.H. 2000. Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem. Sci. 25 (2): 64-70. 10.1016/S0968-0004(99)01519-4. 10664585. (Pubitemid 30100368)
31. Wang M. Zhang W.B. Zhu J.H. Fu G.S. Zhou B.Q. 2009. Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway. Acta Pharmacol. Sin. 30 (8): 1081-1091. 10.1038/aps.2009.95. 19597526.
32. Wang X. McLennan S.V. Allen T.J. Tsoutsman T. Semsarian C. Twigg S.M. 2009. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor. Am. J. Physiol. Cell Physiol. 297 (6): C1490-C1500. 10.1152/ajpcell.00049.2009. 19625611.
33. Wang M. Wang J. Tan R. Wu Q. Qiu H. Yang J. Jiang Q. 2013. Effect of Berberine on PPARa/NO Activation in High Glucose-and Insulin-Induced Cardiomyocyte Hypertrophy. Evid. Based Complement. Alternat. Med. 2013: 285489. 10.1155/2013/285489. 23573121.
34. Yingling J.M. Datto M.B. Wong C. Frederick J.P. Liberati N.T. Wang X.F. 1997. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol. Cell. Biol. 17 (12): 7019-7028. 9372933. (Pubitemid 27505931)
35. Zeller R. Bloch K.D. Williams B.S. Arceci R.J. Seidman C.E. 1987. Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev. 1: 693-698. 10.1101/gad.1.7.693. 2962900.